Glenmark Pharmaceuticals Ltd. NSE: GLENMARK | BSE: 532296

Strong Performer, Getting Expensive

Download real time

2130.90 14.60 (0.69%)

67.06% Gain from 52W Low

808.7K

NSE+BSE Volume

NSE 10 Sep, 2025 3:31 PM (IST)

Dividend

Glenmark Pharmaceuticals Ltd. has an upcoming dividend of ₹2.50 per share due on 15 Sep 2025 See details

Glenmark Pharmaceuticals Ltd. News, Corporate filings and Earnings/Conference Calls

Name: Latest research reports of Glenmark Pharmaceuticals Ltd. authored by ICICI Securities Limited and published by - Trendlyne research reports.
Item: Glenmark Pharmaceuticals Ltd.
Rating: 1
Author: ICICI Securities Limited

Keep track of all breaking news and updates on Glenmark Pharmaceuticals Ltd. from all sources in a single place.

Load latest

Is Glenmark Pharmaceuticals Ltd. worth buying?

571 Votes:

Buy 79.33%

Sell 13.66%

Hold 7.01%

RESEARCH REPORTS

Accumulate SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf